4,446
Participants
Start Date
September 24, 2014
Primary Completion Date
August 6, 2021
Study Completion Date
March 31, 2024
imiquimod
Applied topically
fluorouracil
Applied topically
infrared photocoagulation therapy
Undergo infrared coagulation
thermal ablation therapy
Undergo hyfrecation/electrocautery therapy
laser therapy
Undergo laser therapy
clinical observation
Undergo active monitoring (High Resolution Anoscopy \[HRA\]) with biopsies
laboratory biomarker analysis
Correlative studies
Cornell Clinical Trials Unit, Chelsea Center, New York
Laser Surgery Care, New York
Montefiore - Albert Einstein College of Medicine, The Bronx
Capital Digestive Care, Washington D.C.
Dupont Circle Physicians Group, Washington D.C.
Wake Forest Baptist Health, Winston-Salem
Grady Health System, Atlanta
ACC Clinic, Jackson Hospital, Miami
University of Miami Miller School of Medicine - Sylvester Cancer Center, Miami
Anal Dysplasia Clinic MidWest, Chicago
University Medical Center New Orleans, New Orleans
CrescentCare Health, New Orleans
University of Colorado Hospital, Aurora
Denver Public Health, Denver
UCLA CARE Clinic, Los Angeles
UCLA School of Nursing, Los Angeles
DAP Health, Palm Springs
University of California at San Francisco Anal Dysplasia Clinic, San Francisco
Virginia Mason Medical Center, Seattle
Harborview Medical Center, Seattle
The Polyclinic, Seattle
Boston Medical Center, Boston
Fenway Health, Boston
Rutgers University New Jersey Medical School, Newark
University of Puerto Rico, San Juan
National Cancer Institute (NCI)
NIH
The Emmes Company, LLC
INDUSTRY
University of Arkansas
OTHER
University of California, San Francisco
OTHER
University of Arizona
OTHER
AIDS Malignancy Consortium
NETWORK